Author

Wataru Hashimoto

Observed name: W. Hashimoto

Institution: Daiichi-Sankyo (Japan)

Observed institution: Daiichi-Sankyo (Japan)

ORCID: 0009-0007-3682-502X

Observed ORCID: 0009-0007-3682-502X

OpenAlex ID: A5018380900

Real-world evaluation of interstitial lung disease/pneumonitis in patients treated with trastuzumab deruxtecan for HER2-positive advanced or recurrent gastric cancer: a postmarketing surveillance study in Japan

2025 · H. Kawakami, K. Uchino, et al. · ESMO Open · 10

P2Y12 Reaction Units With Prasugrel in Acute Large Artery Atherosclerosis and Transient Ischemic Attack: An Open-Label Randomized Controlled Study, ACUTE-PRAS

2025 · Shigeru Fujimoto, Yasuyuki Iguchi, et al. · Circulation Journal · 9

Differences in P2Y12 Reaction Units Between Prasugrel and Clopidogrel by Ischemic Cerebrovascular Disease Subtypes ― Subanalysis From ACUTE-PRAS ―

2025 · Shigeru Fujimoto, Yasuyuki Iguchi, et al. · Circulation Reports · 2

P2Y12 Inhibitor Response By Patient Background Factors: An Exploratory Post Hoc Subgroup Analysis of the ACUTE-PRAS Study

2026 · Shigeru Fujimoto, Yasuyuki Iguchi, et al. · Journal of Atherosclerosis and Thrombosis · 1

Real‐World Progression Patterns and Potential Prognostic Factors for Trastuzumab Deruxtecan‐Related Interstitial Lung Disease in Japanese Patients With Breast or Gastric Cancer

2026 · Shinichi Sasaki, Katsunori Oikado, et al. · Cancer Medicine

Clinical Impact of Trastuzumab Deruxtecan in Patients With HER2-Positive Advanced Gastric Cancer and Ascites: Findings From the EN-DEAVOR Study

2026 · Keiko Minashi, Rin Inamoto, et al. · Journal of the Korean Gastric Cancer Association

CORRIGENDUM: P2Y12 Reaction Units With Prasugrel in Acute Large Artery Atherosclerosis and Transient Ischemic Attack: An Open-Label Randomized Controlled Study, ACUTE-PRAS

2025 · Shigeru Fujimoto, Yasuyuki Iguchi, et al. · Circulation Journal

Works count: 7

Citation count: 22

H-index: 2

I10-index: 1